RIO DE JANEIRO, BRAZIL - AstraZeneca's vaccine is in the crucial trial phase with tens of thousands of participants and is considered a great hope. But now the pharmaceutical company has been forced to suspend its trials. One of the test subjects suffered a suspected serious adverse reaction.
The pharmaceutical company has halted the clinical trial of its coronavirus vaccine as a precautionary measure, after one of the subjects experienced adverse effects. This is a . . .